Advancing prenatal diagnosis through comprehensive fetal cell-free DNA screening

Qiong Luo; Yanting Wu; Songchang Chen; Chenming Xu; Dan Zhang; Hefeng Huang; Jinglan Zhang

doi:10.1002/ctm2.70129

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (12) : e70129 DOI: 10.1002/ctm2.70129

COMMENTARY

Advancing prenatal diagnosis through comprehensive fetal cell-free DNA screening

Qiong Luo ¹
, Yanting Wu ²
, Songchang Chen ²
, Chenming Xu ²
, Dan Zhang ¹^,³
, Hefeng Huang ¹^,²^,³^,⁴^,^†
, Jinglan Zhang ¹^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Qiong Luo, Yanting Wu, Songchang Chen, Chenming Xu, Dan Zhang, Hefeng Huang, Jinglan Zhang. Advancing prenatal diagnosis through comprehensive fetal cell-free DNA screening. Clinical and Translational Medicine, 2024, 14(12): e70129 DOI:10.1002/ctm2.70129

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997; 350(9076): 485-487.

[2]	Lun FM, Tsui NB, Chan KC, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA. 2008; 105(50): 19920-19925.

[3]	Xu C, Li J, Chen S, et al. Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening. Cell Discov. 2022; 8(1): 109.

[4]	Zhang J, Wu Y, Chen S, et al. Prospective prenatal cell-free DNA screening for genetic conditions of heterogenous etiologies. Nat Med. 2024; 30(2): 470-479.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.